Artificial Micromotors in the Mouse's Stomach: A Step toward in Vivo Use of Synthetic Motors
Abstract
Artificial micromotors, operating on locally supplied fuels and performing complex tasks, offer great potential for diverse biomedical applications, including autonomous delivery and release of therapeutic payloads and cell manipulation. Various types of synthetic motors, utilizing different propulsion mechanisms, have been fabricated to operate in biological matrices. However, the performance of these man-made motors has been tested exclusively under in vitro conditions (outside the body); their behavior and functionalities in an in vivo environment (inside the body) remain unknown. Herein, we report an in vivo study of artificial micromotors in a living organism using a mouse model. Such in vivo evaluation examines the distribution, retention, cargo delivery, and acute toxicity profile of synthetic motors in mouse stomach via oral administration. Using zinc-based micromotors as a model, we demonstrate that the acid-driven propulsion in the stomach effectively enhances the binding and retention of the motors as well as of cargo payloads on the stomach wall. The body of the motors gradually dissolves in the gastric acid, autonomously releasing their carried payloads, leaving nothing toxic behind. This work is anticipated to significantly advance the emerging field of nano/micromotors and to open the door to in vivo evaluation and clinical applications of these synthetic motors.
Additional Information
© 2014 American Chemical Society. ACS Editors' Choice - This is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes. Received 12 December 2014. Date accepted 30 December 2014. Published online 30 December 2014. Published in print 27 January 2015. This project received support from the Defense Threat Reduction Agency-Joint Science and Technology Office for Chemical and Biological Defense (Grant Nos. HDTRA1-14-1-0064 and HDTRA1-13-1-0002) and from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (Award Number R01DK095168). W.G. is a HHMI International Student Research fellow. R.D. acknowledges the China Scholarship Council (CSC) for the financial support. We thank Michael Galarnyk and Zhiguang Wu for their assistance.Attached Files
Published - nn507097k.pdf
Supplemental Material - nn507097k_si_001.pdf
Supplemental Material - nn507097k_si_002.mpg
Supplemental Material - nn507097k_si_003.mpg
Files
Additional details
- PMCID
- PMC4310033
- Eprint ID
- 82294
- Resolver ID
- CaltechAUTHORS:20171011-151131854
- Defense Threat Reduction Agency (DTRA)
- HDTRA1-14-1-0064
- Defense Threat Reduction Agency (DTRA)
- HDTRA1-13-1-0002
- NIH
- R01DK095168
- Howard Hughes Medical Institute (HHMI)
- China Scholarship Council
- Created
-
2017-10-12Created from EPrint's datestamp field
- Updated
-
2021-11-15Created from EPrint's last_modified field